STUDIES ON THE ROLE OF THE S4 SUBSTRATE BINDING-SITE OF HIV PROTEINASES

被引:64
作者
TOZSER, J
GUSTCHINA, A
WEBER, IT
BLAHA, I
WONDRAK, EM
OROSZLAN, S
机构
[1] NCI, FREDERIC CANC RES & DEV CTR, MOLEC VIROL & CARCINOGENESIS LAB, POB B, FREDERICK, MD 21702 USA
[2] NCI, FREDERIC CANC RES & DEV CTR, CRYSTALLOG LAB, FREDERICK, MD 21702 USA
关键词
HIV PROTEINASE; TYPE-1 AND TYPE-2; OLIGOPEPTIDE SUBSTRATE; ENZYME KINETICS; VARIATE NORMAL DISTRIBUTIONS;
D O I
10.1016/0014-5793(91)80186-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Kinetic analysis of the hydrolysis of the peptide H-Val-Ser-Gln-Asn-Tyr*Pro-Ile-Val-Gln-NH2 and its analogs obtained by varying the length and introducing substitutions at the P4 site was carried out with both HIV-1 and HIV-2 proteinases. Deletion of the terminal Val and Gln had only moderate effect on the substrate hydrolysis, while the deletion of the P4, Ser as well as P'3 Val greatly reduced the substrate hydrolysis. This is predicted to be due to the loss of interactions between main chains of the enzyme and the substrate. Substitution of the P4 Ser by amino acids having high frequency of occurrence in beta-turns resulted in good substrates, while large amino acids were unfavorable in this position. The two proteinases acted similarly, except for substrates having Thr, Val and Leu substitutions, which were better accommodated in the HIV-2 substrate binding pocket.
引用
收藏
页码:356 / 360
页数:5
相关论文
共 27 条
  • [1] EMPIRICAL PREDICTIONS OF PROTEIN CONFORMATION
    CHOU, PY
    FASMAN, GD
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1978, 47 : 251 - 276
  • [2] GENETIC-LOCUS, PRIMARY STRUCTURE, AND CHEMICAL SYNTHESIS OF HUMAN IMMUNODEFICIENCY VIRUS PROTEASE
    COPELAND, TD
    OROSZLAN, S
    [J]. GENE ANALYSIS TECHNIQUES, 1988, 5 (06): : 109 - 115
  • [3] SUBSTITUTION OF PROLINE WITH PIPECOLIC ACID AT THE SCISSILE BOND CONVERTS A PEPTIDE SUBSTRATE OF HIV PROTEINASE INTO A SELECTIVE INHIBITOR
    COPELAND, TD
    WONDRAK, EM
    TOZSER, J
    ROBERTS, MM
    OROSZLAN, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 169 (01) : 310 - 314
  • [4] COPELAND TD, 1990, GENE ANAL TECHNOL, V169, P310
  • [5] DARKE PL, 1989, J BIOL CHEM, V264, P2307
  • [6] DESIGN, ACTIVITY, AND 2.8 A CRYSTAL-STRUCTURE OF A C2 SYMMETRICAL INHIBITOR COMPLEXED TO HIV-1 PROTEASE
    ERICKSON, J
    NEIDHART, DJ
    VANDRIE, J
    KEMPF, DJ
    WANG, XC
    NORBECK, DW
    PLATTNER, JJ
    RITTENHOUSE, JW
    TURON, M
    WIDEBURG, N
    KOHLBRENNER, WE
    SIMMER, R
    HELFRICH, R
    PAUL, DA
    KNIGGE, M
    [J]. SCIENCE, 1990, 249 (4968) : 527 - 533
  • [7] FFITZGERALD PMD, 1990, J BIOL CHEM, V265, P14209
  • [8] SELECTIVE PHOSPHINATE TRANSITION-STATE ANALOG INHIBITORS OF THE PROTEASE OF HUMAN-IMMUNODEFICIENCY-VIRUS
    GROBELNY, D
    WONDRAK, EM
    GALARDY, RE
    OROSZLAN, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 169 (03) : 1111 - 1116
  • [9] COMPARISON OF INHIBITOR BINDING IN HIV-1 PROTEASE AND IN NONVIRAL ASPARTIC PROTEASES - THE ROLE OF THE FLAP
    GUSTCHINA, A
    WEBER, IT
    [J]. FEBS LETTERS, 1990, 269 (01) : 269 - 272
  • [10] Henderson L.E., 1988, UCLA S MOL CELL BIOL, V71, P135